Healthcare Industry News: Smiths Medical
News Release - April 3, 2006
Smiths Medical Wins $3 Million Contract With Massachusetts General HospitalCARLSBAD, Calif., April 3 (HSMN NewsFeed) -- Smiths Medical has announced a $3.4 million contract with Massachusetts General Hospital (MGH) for purchase of 1,365 Medfusion(TM) 3500 Syringe Pumps. Signed in July 2005, this agreement stipulates delivery of Medfusion(TM) 3500 Syringe Pumps with PharmGuard(TM) Medication Safety Software -- the most recent innovation in Smiths Medical's infusion technology -- for use by many departments at MGH.
The Medfusion(TM) 3500 Syringe Pump with PharmGuard(TM) Medication Safety software is a leading-edge infusion system that incorporates specific configuration profiles, a drug library composed of more than 4,000 entries, over 100 dosing units, and safety dose limits on all infusion parameters to help reduce medication errors that may otherwise occur. This smart pump's rapid occlusion detection technology with FlowSentry(TM) advanced pressure technologies offers a comprehensive array of pressure-related safety features, and its graphic display of pressure trend allows for earlier clinical intervention. The Medfusion(TM) 3500 Syringe Pump imports and exports data and protocols, and may be adapted and customized to interface with bedside environment. Its PharmGuard(TM) safety software reports provide valuable information required for improved processes and medication delivery practices in the critical care environment.
"This contract presents a great opportunity to demonstrate the effectiveness and versatility of Medfusion(TM) 3500's safety technology and data integration systems," stated John Bond, Global Director of Marketing for Safety Infusion Systems at Smiths Medical. "The use of Medfusion 3500(TM) Syringe Pumps in adult and pediatric departments of such a remarkable institution further enhances Smiths Medical's presence and reputation in critical care environments across the nation."
"The MGH is committed to providing the highest quality, safest care possible to all patients," says Ellen Kinnealy, RN, of MGH Biomedical Engineering. "The use of smart pumps, which contain vital information about specific medications, has enabled the hospital to make significant advancements in the capability and safety of intravenous drug infusion systems. This technology is an important way to prevent errors and enhance clinical care. In fact, it can help raise the standard of medical care throughout the country."
Massachusetts General Hospital is a world-renowned, 898-bed hospital located in Boston, Massachusetts. Founded in 1811, it is the oldest and largest teaching hospital of Harvard Medical School. This medical center offers sophisticated diagnostic and therapeutic care in virtually every specialty and subspecialty of medicine and surgery with more than 3,500 births and 34,000 surgical cases each year. It is consistently ranked by U.S. News and World Reports as one of the top U.S. hospitals.
About Smiths Medical
Smiths Medical is a clinically-focused global leader in the design, manufacture, and distribution of medical devices used for a variety of therapeutic, diagnostic, and surgical procedures. The company's portfolio includes airway management, pain management, temperature management systems, infusion systems, implantable access systems, safety I.V. catheters, critical care monitoring, and insulin delivery systems. This product range offers customers clinical and economical advantages backed by experience, innovation, and value-added services, including extensive product training and support. For more information, visit the company's web site at www.smiths-medical.com.
Source: Smiths Medical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.